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Background
CD8+ T-cells have long been shown to be important for
control of HIV-1 infection, though it is clear that not all
CD8+ T-cell responses are equal. For the best chance of
producing a successful vaccine, it is crucial to define which
responses lead to better disease outcomes. Many studies
have correlated HIV-specific T-cell responses with slower
HIV disease progression; however, a causal relationship
has not been clearly defined. Tetramers to antigen-specific
cells allow enumeration, characterization and separation
of cell populations, allowing comparison of their viral
suppressive capabilities in downstream assays.
Methods
Tetramers were used to enumerate HIV-1 antigen-specific
CD8+ T-cells in PBMCs from HIV infected subjects, on a
BD LSR-II flow cytometer. A protocol for expansion of
these epitope-specific cells was developed in control sam-
ples using the CMV peptide NLVPMVATV due to its
immunodominance in North America. Cells were stimu-
lated for 10 days with varying concentrations of IL-2, IL-7
and IL-15 along with the tetramer-matched peptide to elu-
cidate optimal expansion conditions.
Results
Initially, ~0.5%–1.5% of CD8+ T-cells bound to HIV-1
specific tetramers in HIV-1 infected subjects. These low
cell numbers identified a need for expansion of the cells
for use in downstream assays. In our protocol, addition of
IL-15 and peptide results in an increase of tetramer+ cells
from 3.5% to 85% of total CD8+ T-cells, while IL-2 and
IL-7-induced responses were less robust. Increasing the
concentrations or adding multiple cytokines at once
decreased the population of tetramer+ T-cells to less than
1%.
Conclusion
These results indicate that antigen-specific T-cells can be
expanded to high levels for use in subsequent assays, such
as a study of their HIV-1 suppressive capabilities. This will
provide a direct link between specific CD8+ T-cells and
viral control, which will be key in determining which
responses are most likely to be effective in an HIV-1 vac-
cine.
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